Please login to the form below

Not currently logged in
Email:
Password:

LHON

This page shows the latest LHON news and features for those working in and with pharma, biotech and healthcare.

Santhera closer to filing for muscular dystrophy drug

Santhera closer to filing for muscular dystrophy drug

Santhera had previously filed for approval of the drug as a treatment for the rare eye condition Leber's hereditary optic neuropathy (LHON) but had its application turned down by the

Latest news

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Kantar Health

Kantar Health is a leading global healthcare consulting firm and trusted advisor to many of the world’s leading pharmaceutical, biotech,...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics